Amanote Research
Register
Sign In
Risks of Reformulation: French Patients Complain After Merck Modifies Levothyroxine Pills
British Medical Journal
- United Kingdom
doi 10.1136/bmj.k920
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
February 23, 2018
Authors
Unknown
Publisher
BMJ
Related search
Pills, Policies, and Patients
Health Affairs
Medicine
Health Policy
94% of Patients Suing Merck Over Rofecoxib Agree to Company's Offer
British Medical Journal
Medicine
Merck Award
Chemical and Engineering News
Chemical Engineering
The Dilemma of Levothyroxine Replacement Timing: Comparison of Bedtime Versus Early-Morning Replacement of Levothyroxine in Post Total Thyroidectomy Patients
International Surgery Journal
The Merck Index
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients With Atrophic Thyroid After Radioiodine Treatment for Graves' Disease
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Next Generation Production @ Merck
Chemie-Ingenieur-Technik
Chemistry
Chemical Engineering
Manufacturing Engineering
Industrial
Regulating Risks After "ATA"
Supreme Court Review
Law
Dr. E. A. Merck
Nature
Multidisciplinary
